2026年度
 附属病院がんセンター臨床腫瘍科
■ 当該年度研究業績数一覧表
研究者名 論文 著書 学会発表 その他
発表
和文英文 和文英文 国内国際














金井 雅史   センター教授
 0 0 0 1  0 0 0 0  0  0  0  0  0  0
柴田 伸弘   センター診療講師
 0 0 0 4  0 0 0 0  0  0  1  1  0  0
朴 将源   センター診療講師
 0 0 1 3  0 0 0 0  0  0  0  0  0  0
安田 知代   センター助教
 0 0 0 0  0 0 0 0  0  0  0  0  0  0
長田 巧平   センター助教
 0 0 0 0  0 0 0 0  0  0  0  0  0  0
 0 0 1 8  0 0 0 0  0  0  1  1  0  0
■ 学術雑誌
原著
1. Manami Tada, Yuichiro Kikawa, Nobuhiro Shibata, Chie Hirai, Hirotsugu Yanai, Masahiro Takada, Tomoharu Sugie:  Efficacy of olanzapine for prophylaxis of delayed chemotherapy-induced nausea and vomiting in patients with breast cancer receiving dose-dense AC with a steroid-sparing regimen: a single-center pilot study.  BMC cancer  26 (1) :625 , 2026
2. Yukinori Ozaki, Shohei Koyama, Satoshi Morita, Minoru Miyashita, Emi Tokuda, Tatsunori Shimoi, Megumi Fukuoka, Hiroko Masuda, Yuko Takano, Nobuhiro Shibata, Tetsuhiro Yoshinami, Akari Murakami, Kentaro Tamaki, Hiroshi Ishiguro, Shigehira Saji, Asako Miwa, Junko Matsunaga, Yue Zheng, Hiroyoshi Nishikawa, Norikazu Masuda:  Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10).  BMJ open  16 (5) :e098088 , 2026
3. Masashi Kanai, Kuniko Sunami, Tatsunori Shimoi, Satoshi Nishiwaki, Ichiro Kinoshita, Tetsuhiro Yoshinami, Chigusa Morizane, Yusuke Sato, Toshio Kubo, Mamoru Ito, Hiroshi Nishihara, Toru Mukohara, Hidekazu Shirota, Ryo Ko, Taro Shibata, Manabu Muto, Noboru Yamamoto:  Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.  Cancer science  :Online ahead of print. , 2026
4. Kyosuke Seguchi, Takao Fujisawa, Sadakatsu Ikeda, Yu Oyama, Norio Nonomura, Chigusa Morizane, Hiroji Iwata, Susumu Okano, Hidemichi Watari, Kenjiro Namikawa, Shigenori Kadowaki, Makoto Ueno, Eiji Oki, Shogen Boku, Satoshi Yuki, Wataru Yamagami, Tomohiro Nishina, Tishihiro Kudo, Naoki Takahashi, Hideaki Bando, Takayuki Yoshino, Yoshiaki Nakamura:  Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss Across Advanced Solid Tumors.  Clinical cancer research : an official journal of the American Association for Cancer Research  :Online ahead of print , 2026
5. Shunji Endo, Yutaka Kimura, Naotoshi Sugimoto, Ryohei Kawabata, Atsushi Takeno, Shigeyuki Tamura, Jin Matsuyama, Masato Nakamura, Hiroki Takeshita, Motohiro Imano, Atsushi Yasuda, Hironaga Satake, Shogen Boku, Masahito Kotaka, Tomohira Takeoka, Yukinori Kurokawa, Toshimasa Tsujinaka, Toshio Shimokawa, Taroh Satoh:  Long-term survival outcomes from a phase II trial of perioperative capecitabine plus oxaliplatin for advanced gastric cancer with extensive lymph node metastases: OGSG 1701.  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association  29 (3) :611 -621 , 2026
6. Erika Iguchi, Motoki Watanabe, Kaito Kobayashi, Shogen Boku, Wataru Nishio, Chikage Kato, Midori Morita, Koichi Sakaguchi, Michihiro Mutoh, Tomoshi Kameda, Yasuto Naoi:  Identification of ANT2 as a Druggable Target for Endocrine-Resistant ERα-Positive Breast Cancer.  International journal of molecular sciences  27 (8) :3704 , 2026
7. Tatsunori Shimoi, Nobuhiro Shibata, Masahiro Kitada, Michiko Tsuneizumi, Mitsugu Yamamoto, Yukinori Ozaki, Yumi Fujimoto, Sayuri Akiyoshi, Naoki Hashimoto, Miki Yamaguchi, Yutaka Yamamoto, Norikazu Masuda, Hiroshi Tada, Takashi Yamanaka, Yuichiro Kikawa, Tetsuhiko Taira, Shizuka Nakagawa, Taizo Takashashi, Mari S. Oba, and Naoki Niikura.:  Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.  NPJ Breast Cancer  :Online ahead of print , 2026
症例報告
1. Ryohei Fujii, Nobuhiro Shibata, Yuichiro Kikawa; Shinya Fujita; Yuri Noda, Mikiko Kasahara; Chie Hirai, Manami Tada; Hirotsugu Yanai; Tomoharu Sugie; Masahiro Takada:  Early-onset DAT-negative autoimmune hemolytic anemia induced by pembrolizumab in perioperative triple-negative breast cancer: a case report.  Case Reports in Oncology  Online ahead of print , 2026
2. Shogen Boku, Takao Fujisawa, Shigenori Kadowaki, Hironaga Satake, Hisateru Yasui, Koushiro Ohtsubo, Yasushi Shimizu, Tomoyuki Otsuka, Bunya Kuze, Riu Yamashita, Taro Shibuki, Yoshiaki Nakamura, Hideaki Bando, Takayuki Yoshino, Milan Radovich, Susumu Okano:  Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib.  JCO precision oncology  10 (7) :e2600237 , 2026
■ 学会発表
国際学会及び海外の学会
1. Sayaka Kuba, Yasuhiro Hagiwara, Nobuhiro Shibata, Takafumi Sangai, Ryoichi Matsunuma, Uhi Toh, Kenichi
Watanabe, Takayuki Iwamoto, Kosho Yamanouchi, Michiko Harao, Miki Yamaguchi, Masahiko Suzuki, Shigeto
Maeda, Noriko Maeda, Akiko Ebata, Nobutaka Iwakuma, Sakiko Soutome, Takeshi Yamaguchi, Yuichiro Kikawa,
Hirofumi Mukai: A randomized phase III trial of dexamethasone mouthwash to prevent chemotherapy-induced oral mucositis in patients with breast cancer: SMASH-BC.  American Society of Clinical Oncology (ASCO) Annual Meeting 2026,  Chicago, IL, USA.,  2026/05
2. Nobuhiro Shibata, Yukinori Ozaki, Toshikazu Fukami, Mako Ikeda, Hiroaki Kato, Takashi Morimoto, Kentaro Tamaki, Mitsugu Yamamoto, Takuho Okamura, Tetsuhiko Taira, Noriko Maeda, Koji Matsumoto, Akihiko Shimomura, Taiyu Sumida, Akifumi Kurata, Tadahiro Izutani, Naoki Niikura, Yuichiro Kikawa: Wearable-derived physical activity monitoring with AI-based detection of
treatment-related adverse events during neoadjuvant chemotherapy for early
breast cancer: TRACK-BC.  American Society of Clinical Oncology (ASCO) Annual Meeting 2026,  Chicago, IL, USA.,  2026/05